Back to PathoKing

MG module

Myasthenia Gravis

Understand myasthenia gravis as antibody-mediated failure of postsynaptic neuromuscular transmission causing fatigable ocular, bulbar, limb and respiratory weakness.

intermediate40 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What underlies or worsens MG?

Autoimmune subtype, thymic disease and physiological stress shape presentation and deterioration.

AChR autoimmunity

Typical setting: The commonest antibody-defined generalised subtype.

IgG targets postsynaptic receptors and recruits complement, reducing receptor density and damaging junctional folds.

MuSK or LRP4 autoimmunity

Typical setting: Seronegative AChR testing with compatible disease, often prominent bulbar weakness.

Antibodies disrupt the signalling scaffold that clusters and maintains functional receptors.

Thymoma

Typical setting: Anterior mediastinal tumour associated with MG.

Abnormal thymic selection permits autoreactive T cells; all confirmed MG requires appropriate thymic assessment.

Infection and physiological stress

Typical setting: Sudden worsening during infection, surgery, pregnancy or postpartum change.

Inflammation, fever, altered medication delivery and increased respiratory demand expose limited neuromuscular reserve.

Medicine-related worsening

Typical setting: Selected antibiotics, magnesium, beta-blockers, anaesthetic agents and other drugs.

Presynaptic release, postsynaptic responsiveness or respiratory reserve may be impaired; risk is drug- and patient-specific and requires clinical review rather than blanket withdrawal.

Mechanism chain

Mechanism chain

Antibodies reduce postsynaptic reserve until repeated impulses fail to trigger contraction.

1

Tolerance to junctional proteins is lost

Autoreactive T and B cells generate antibodies against AChR, MuSK, LRP4 or related targets.

2

The postsynaptic membrane is disrupted

Receptor blockade/internalisation, complement injury or failed receptor clustering reduces effective acetylcholine signalling.

Checking account access...